Name

AiPing Pharmaceutical

Legal name

AiPing Pharmaceutical, Inc.

Website

https://aipingpharmaceutical.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Hauppauge

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Generic Pharmaceutical Product Sales: Revenue generated from manufacturing and selling generic prescription and OTC pharmaceutical products including tablets, capsules, and soft gels. Products are sold through distribution channels to healthcare providers and pharmacies.
2. Product Acquisition and Commercialization: Company acquires, redevelops, and commercializes mature, under-serviced or under-supplied generic molecules. Provides product development, regulatory filing, and commercial production services.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

AiPing Pharmaceutical is a generic pharmaceutical manufacturer that develops, manufactures, and commercializes oral solid dose generic prescription drugs, over-the-counter medications, and nutritional supplements. The company offers a portfolio of 30+ products across tablets, capsules, soft gels, oral suspensions, powders, and stick packs, supported by integrated R&D, cGMP-compliant manufacturing with capacity of up to 5 billion pills annually, packaging, and quality services. Products are sold through authorized distributors and direct B2B channels to healthcare providers, pharmacies, and institutional buyers in the US market.

Product overview

AiPing Pharmaceutical is a generic pharmaceutical manufacturer that operates as a portfolio of prescription products, OTC products, and nutritional supplements organized under a unified brand. The product portfolio includes 16 distinct generic prescription medications spanning multiple therapeutic categories (antidepressants, antibiotics, anxiolytics, antihypertensives, NSAIDs, statins, antiplatelets, and more) in various dosage forms (tablets, capsules, oral suspensions). These products are complemented by OTC medications and premium nutritional supplements. The company provides end-to-end capabilities including product development, regulatory filing, and commercial production, with manufacturing capacity of up to five billion pills annually across two facilities totaling 175,000 sq.ft.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription Products Portfolio of generic prescription pharmaceutical products including tablets, capsules, and soft gels in oral solid dose formulations, sold to healthcare providers, pharmacies, and institutional buyers.
• Over The Counter (OTC) Products Portfolio of OTC generic pharmaceutical products available without prescription, sold through B2B channels to pharmacies and retailers.
• Nutritional Supplements Premium pharmaceutical-grade supplements designed to promote healthy, active lifestyles at any age, sold through pharmacy and B2B channels.
• Amitriptyline HCl Tablets Generic tricyclic antidepressant tablets available in 10mg, 25mg, 50mg, 75mg, 100mg, and 150mg strengths; brand reference Elavil.
• Azithromycin for Oral Suspension USP Generic antibiotic powder for oral suspension in 100mg/5mL and 200mg/5mL strengths; brand reference Zithromax.
• Buspirone Tablets Generic anti-anxiety medication available in 5mg, 7.5mg, 10mg, 15mg, and 30mg strengths; brand reference Buspar.
• Captopril Tablets Generic ACE inhibitor for hypertension available in 12.5mg, 25mg, 50mg, and 100mg strengths; brand reference Capoten.
• Celecoxib Capsules Generic COX-2 inhibitor NSAID available in 50mg, 100mg, 200mg, and 400mg strengths; brand reference Celebrex.
• Doxycycline Capsules Generic tetracycline antibiotic capsule in 40mg strength; brand reference Oracea.
• Haloperidol Tablets Generic antipsychotic tablets available in 0.5mg, 1mg, 2mg, 5mg, 10mg, and 20mg strengths; brand reference Haldol.
• Ibuprofen Tablets Generic NSAID pain reliever available in 400mg, 600mg, and 800mg strengths; brand reference Motrin.
• Losartan Potassium Tablets Generic angiotensin receptor blocker for hypertension available in 25mg, 50mg, and 100mg strengths; brand reference Cozaar.
• Meloxicam Tablets Generic NSAID available in 7.5mg and 15mg strengths; brand reference Mobic.
• Metformin HCl ER Tablets Generic extended-release metformin for diabetes management available in 500mg and 1000mg strengths; brand reference Fortamet.
• Methimazole Tablets Generic antithyroid medication available in 5mg and 10mg strengths; brand reference Tapazole.
• Rosuvastatin Calcium Tablets Generic statin for cholesterol management available in 5mg, 10mg, 20mg, and 40mg strengths; brand reference Crestor.
• Sevelamer Carbonate Tablets Generic phosphate binder for chronic kidney disease patients in 800mg strength; brand reference Renvela.
• Sotalol HCl Tablets Generic antiarrhythmic medication available in 80mg, 120mg, 160mg, and 240mg strengths; brand reference Betapace.
• Ticagrelor Tablets Generic antiplatelet medication available in 60mg and 90mg strengths; brand reference Brilinta.
• Research & Development Services R&D services focused on pre-formulation studies, formulation studies, analytical development, manufacturing, and packaging solutions for global markets.
• Manufacturing & Packaging Services State-of-the-art manufacturing and packaging services across 175,000 sq.ft. facilities with capacity up to 5 billion pills per year, including tablets, capsules, powder filling, stick packs, bottle filling, and blister packaging.
• Quality Services Quality control services with world-class facilities and high-precision laboratory equipment for testing and releasing products, including vendor audits.

Quantifiable outcome

• Manufacturing capacity of 5 billion pills per year

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Three partnerships are on record, tiered operational and core.

• EVERSANAoperationalTechnology or IntegrationEVERSANA provides operational support for AiPing including EDI technical support, ASN and 856 inquiry handling, and accounts receivable management through [email protected]. They serve as a technology and service partner for supply chain and financial operations.
• TraceLinkoperationalTechnology or IntegrationTraceLink provides DSCSA (Drug Supply Chain Security Act) network links and systems for AiPing Pharmaceutical. AiPing is contracted with TraceLink for compliance with drug traceability requirements including GLN, SGLN, and GTIN systems.
• Authorized DistributorscoreChannel Partner/ Reseller/ DistributorAiPing maintains a network of authorized distributors for pharmaceutical product distribution. The list of authorized distributors is published and available through FDA systems.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lannett Company: US-focused generic drug developer and manufacturer specializing in oral solid dose generics and a focused niche molecule strategy. Mid-scale generics manufacturer with overlapping product categories and US distribution model.
• Upsher-Smith Laboratories: US-based private generic pharmaceutical manufacturer focused on oral solid and specialty generics, including niche and difficult-to-formulate molecules. Comparable mid-sized US generics manufacturer with similar specialty/generic hybrid approach.
• ANI Pharmaceuticals: US specialty generic pharmaceutical company developing, manufacturing, and marketing generic prescription pharmaceuticals, with emphasis on rare/orphan and niche generics. Comparable mid-sized US generics manufacturer with similar niche molecule focus.
• Apotex Inc. Largest Canadian-owned generic pharmaceutical manufacturer producing oral solid dose, injectable, and topical generics across therapeutic categories. Comparable vertically integrated generic pharma manufacturer competing for US generic share.
• Amneal Pharmaceuticals: US-based developer, manufacturer, and marketer of generic and specialty pharmaceuticals across oral solids, injectables, and biosimilars. Closely comparable business model to AiPing: vertically integrated generic manufacturer with manufacturing scale and broad ANDA portfolio.

Broad incumbents

• Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with one of the largest US ANDA portfolios (via Aurobindo USA/AuroMedics), with strong overlap in oral solids, injectables, and CNS/cardiovascular generics.
• Sun Pharmaceutical Industries: India-based global specialty and generic pharmaceutical manufacturer with significant US generics business (including through Taro). Competes aggressively on price in oral solid generics overlapping AiPing's portfolio.
• Sandoz (Novartis generic division): Standalone global generics manufacturer with deep US presence across oral solids, injectables, and biosimilars. Major ANDA holder overlapping many of AiPing's product categories and the global pricing benchmark.
• Viatris (formerly Mylan/Upjohn): Global generics and specialty company formed from Mylan and Upjohn, with a large US generics footprint across oral solids and biosimilars. Competes broadly in the same molecule categories AiPing serves.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with extensive US generics portfolio across oral solids, injectables, and biosimilars. Indirect competitor through overlap on many of AiPing's molecules and provides overall pricing benchmark for US generics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/a&z-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AiPing Pharmaceutical